x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Proactive - Interviews for investors

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage. Here we plug you into what’s new and exciting in the world of business.

business investing

All Episodes

00:05:45

VSPC expansion plans detailed by Livium CEO

Proactive - Interviews for investors ·

2025/04/01

Livium Ltd CEO Simon Linge talked with Proactive about the company's progress on its lithium ferro phosphate (LFP) demonstration plant and strategic growth plans. The company is working to secure the remaining A$30.00 million to fully fund the plant, with Linge stating that the process involves "complex transactions" and that "there's a bit to be thought through". The funding includes support from a substantial A$30.00 million grant from the Australian Renewable Energy Agency (ARENA), which covers

en

00:03:27

Nevis Brands doubles revenue in 2024, cuts losses &...

Proactive - Interviews for investors ·

2025/03/28

Nevis Brands CEO John Kueber joined Steve Darling from Proactive to discuss the company’s financial results for fiscal year 2024 and the fourth quarter ending November 30, 2024. Nevis reported $1.56 million in revenue, more than doubling its 2023 sales as it expanded into new markets and introduced new cannabis products.The company narrowed its net loss to approximately $362,000, down from $400,000 the previous year. When excluding interest, depreciation, and amortization, the adjusted loss was

en

00:06:06

Brazil Potash’s Autazes Project fully permitted,...

Proactive - Interviews for investors ·

2025/03/28

Brazil Potash CEO Matt Simpson joined Steve Darling from Proactive providing key updates on the company’s Autazes Potash Project in northwest Brazil. The project has successfully completed all necessary permitting milestones—including technical, environmental, indigenous, and public consultations—clearing the way for full-scale construction. Brazil, which currently imports 98% of its potash, remains heavily reliant on foreign supply. The Autazes Project is designed to address this dependency by

en

00:06:38

Biome Australia expands global footprint, targets...

Proactive - Interviews for investors ·

2025/03/27

Biome Australia Managing Director Blair Norfolk joined Steve Darling from Proactive to talk about the company’s expansion strategy and continued growth in clinically validated, condition-specific probiotics. As a leader in live biotherapeutics, Biome Australia has developed probiotics with proven benefits across various health conditions, including mental health, asthma, cardiovascular health, and skin care.The company has over 20 clinical trials validating its products in those areas including

en

00:08:18

Sintana Energy advances Orange Basin portfolio with...

Proactive - Interviews for investors ·

2025/03/27

Sintana Energy CEO Robert Bose recently spoke with Steve Darling from Proactive to provide a comprehensive update on the company’s Orange Basin assets, highlighting significant progress across PEL 83, PEL 90, PEL 87, and PEL 82. Bose sahred positive results from the Mopane 3-X well on PEL 83, operated by Galp. The well, which targeted new AVO anomalies 10 and 13, delivered better-than-expected results across nearly every parameter, confirming the presence of high-quality oil and condensate. This

en

00:04:59

Lithium ION Energy secures joint venture with SureFQ...

Proactive - Interviews for investors ·

2025/03/27

Lithium ION Energy Limited CEO Ali Haji joined Steve Darling from Proactive to announce a binding Joint Venture Agreement with SureFQ for the advancement of the Urgakh Naran lithium project in Mongolia. Under the agreement, ION will retain a 20% free carried interest through to commercial production, ensuring long-term participation in the project's success without additional financial commitments. SureFQ, a firm specializing in sustainable energy solutions and lithium resource development, will

en

00:06:02

Candel Therapeutics shares positive survival data for...

Proactive - Interviews for investors ·

2025/03/27

Candel Therapeutics CEO Dr. Paul Peter Tak joined Steve Darling from Proactive to announce final survival data from a Phase 2a clinical trial evaluating the company’s investigational immunotherapy in patients with stage III/IV non-small cell lung cancer (NSCLC) who had an inadequate response to immune checkpoint inhibitor (ICI) treatment. The study reported a median overall survival (mOS) of 24.5 months in 46 evaluable patients who received two courses of the investigational therapy. In a subset of

en

00:04:10

Nextech3D.ai unveils AI-powered customer service...

Proactive - Interviews for investors ·

2025/03/27

Nextech3D.ai CEO Evan Gappelberg joined Steve Darling from Proactive to introduce the company’s latest innovation: an AI-powered customer service chat agent designed to enhance customer interactions and drive sales. This cutting-edge virtual assistant, integrated directly into Nextech3D.ai’s website, features advanced voice technology from Eleven Labs, enabling natural, human-like conversations. The AI chatbot is engineered to streamline customer support with a range of capabilities, including

en

00:07:19

Technology Minerals CEO on black mass and Leinster...

Proactive - Interviews for investors ·

2025/03/27

Technology Minerals CEO Alex Stanbury talked with Proactive's Stephen Gunnion about a milestone week for the company, highlighting significant progress in both its recycling operations and exploration asset portfolio. Stanbury discussed the first shipment of black mass from its Recyclus facility to Europe, under an agreement with Glencore. He explained that black mass—a hazardous material containing lithium, cobalt, and nickel—requires complex approvals for cross-border movement. “It’s been a lot

en

00:04:02

EnWave expands footprint with commercial license in...

Proactive - Interviews for investors ·

2025/03/27

EnWave Corporation CEO Brent Charleton joined Steve Darling from Proactive to announce the company has signed a commercial license agreement with Hokkai Yamato Foods Japan, a leading producer of processed foods such as soups, furikake, and ochazuke. As part of the agreement, Hokkai Yamato has acquired a 10kW Radiant Energy Vacuum (REV™) machine to drive product development and support early-stage commercial production in Japan.This license grants Hokkai Yamato exclusive rights to use EnWave’s

en

00:06:52

Chesnara CEO discusses strong 2024 results, dividend...

Proactive - Interviews for investors ·

2025/03/27

Chesnara PLC (LSE:CSN) CEO Steve Murray talked to Proactive's Stephen Gunnion about the company’s strong 2024 full-year results, highlighting robust cash generation and consistent dividend growth. Murray highlighted that Chesnara generated £60 million in cash over the year, providing strong dividend coverage and supporting its 20-year track record of uninterrupted dividend growth. The business also increased its overall value and maintained a strong solvency position. The interview also covered

en

00:05:56

Sprintex secures A$3.25m to expand global output;...

Proactive - Interviews for investors ·

2025/03/27

Sprintex Ltd (ASX:SIX) managing director and CEO Jay Upton talked with Proactive's Stephen Gunnion about the company’s successful A$3.25 million capital raise, drawing strong backing from both existing shareholders and new institutional investors. Upton said approximately A$1.5 million of the funds would go toward debt reduction, with the remaining A$1.75 million allocated to accelerating production and sales of Sprintex’s new range of high-speed electric compressors. These products aim to improve

en

00:11:15

Ecora Resources sees strong 2024 results as cobalt,...

Proactive - Interviews for investors ·

2025/03/27

Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) CEO Marc Bishop Lafleche takes Proactive's Stephen Gunnion through the company’s full-year 2024 financial results and the strategic progress made across its royalty portfolio. Lafleche reported a strong performance in 2024 despite challenging market conditions, citing volume growth at Voisey’s Bay as a key highlight, even as cobalt prices approached 50-year lows. He said, “Since year-end, actually, it's amazing how quickly things can change,”

en

00:06:56

Genflow Biosciences CEO welcomes new investment;...

Proactive - Interviews for investors ·

2025/03/26

Genflow Biosciences PLC CEO Dr Eric Leire talked with Proactive's Stephen Gunnion about a pivotal new direction for the company as it initiates a clinical trial focused on improving aging in dogs.Leire described the trial as a natural evolution from Genflow's previous success in mice, noting the commercial appeal of the canine market. “There is nothing to improve really the quality of life of our aging dogs,” he said, adding that the study meets a significant unmet need. The trial will run for

en

00:03:41

Opioid-Free pain relief: AFT’s global expansion strategy

Proactive - Interviews for investors ·

2025/03/26

AFT Pharmaceuticals Ltd Managing Director Dr Hartley Atkinson talked with Proactive at the AIM's Small and Midcap Conference about the company's unique approach to drug development, its expanding global footprint, and what lies ahead in 2025. AFT Pharmaceuticals is focused on creating pharmaceuticals "with a difference," targeting unmet needs and reducing reliance on opioids. “We don’t sell anything we don’t believe in,” said Dr Atkinson, highlighting the importance of alternatives to opioid

en

00:05:20

Actinogen targets $20B Alzheimer’s market with Xanamem

Proactive - Interviews for investors ·

2025/03/26

Actinogen Medical Ltd Managing Director and CEO Dr Stephen Gourlay talked with Proactive at the AIM's Small and Midcap conference about the company’s lead asset, Xanamem, and its development in Alzheimer’s disease and depression. Dr Gourlay explained that Xanamem is an oral, once-a-day drug designed to modulate cortisol levels in the brain without interfering with the body’s essential stress response. “We’ve also shown some positive data, you know, phase two and depression as well, which is very

en

00:06:35

Alpha HPA eyes global demand with stage 2 facility

Proactive - Interviews for investors ·

2025/03/26

Alpha HPA Ltd Managing Director Rob Williamson talked with Proactive at the AIM Small and Midcap conference about how the company is redefining aluminum purification through its novel solvent extraction technology. Alpha HPA is producing high-purity aluminum materials for advanced industries such as semiconductors, lithium-ion batteries, direct lithium extraction, and LED technologies. Williamson explained that while solvent extraction has been used in industries like copper and rare earths, Alpha

en

00:05:31

Saunders expands defense & fuel infrastructure work

Proactive - Interviews for investors ·

2025/03/26

Saunders International Ltd Managing Director and CEO Mark Benson talked with Proactive at the AIM's Small and Midcap Conference about the company’s strong momentum, recent project wins and the strategic expansion into defense and infrastructure sectors. Benson highlighted Saunders’ transformation from a tank constructor to a multi-disciplined, end-to-end engineering and construction provider. “We’ve diversified and become a multi-disciplined business… Now some of the projects we can do end-to-end,”

en

00:05:46

SomnoMed lifts revenue 19% amid soaring demand

Proactive - Interviews for investors ·

2025/03/26

SomnoMed CO-CEOs Amrita Blickstead and Karen Borg talked with Proactive about the company’s performance and opportunities in the global sleep apnea treatment market. The company, which develops proprietary oral appliances for obstructive sleep apnea, is seeing significant demand as patients seek alternatives to traditional CPAP therapy. “About 60% of people fail to be able to use actual CPAP therapy because it’s quite invasive,” Borg explained. SomnoMed’s devices offer a less intrusive solution

en

00:07:29

BluGlass talks quantum sensing & commercial wins

Proactive - Interviews for investors ·

2025/03/26

BluGlass Head of Corporate and Investor Relations Stefanie Winwood talked with Proactive at the AIM's Small and Midcap Conference about the company’s work in gallium nitride (GaN) laser technology and its growing role in quantum sensing, computing, and defense applications. Winwood explained that gallium nitride is a compound semiconductor that can conduct electrons significantly faster than traditional silicon. BluGlass is one of a few companies globally producing visible lasers using GaN, a

en

4,685 results

Similar Podcasts

Bloomberg Talks

Bloomberg

Minute Briefing

The Wall Street Journal

Fintech Insider Podcast by 11:FS

11:FS

Midday News

Multimedia Ghana

Best of Business

Newstalk ZB